SeraCare Life Sciences, Inc

Life sciences company, Cellular Technology partner on immune reactivity testing

Published in Pharma Law Weekly, January 4th, 2005

SeraCare Life Sciences, Inc. (SRLS), a provider of biological materials and services for research, and Cellular Technology Ltd. (CTL), manufacturer of ELISPOT instruments for immune reactivity testing, announced a collaboration to deliver products and services to the immune reactivity testing market.

The ELISPOT platform has led to CTL's position in immune diagnostics. The method is used to determine the effectiveness of vaccines and drugs to stimulate or inhibit the human immune system. The most effective vaccines and immune-stimulating drugs are likely to be those that stimulate a high number of specific white cells to produce key immune stimulation byproducts, known...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2005-01-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry